Atrys Health, S.A. (BME:ATRY)
2.960
-0.060 (-1.99%)
At close: Feb 26, 2026
Atrys Health Market Cap
Atrys Health has a market cap or net worth of €224.59 million as of February 26, 2026. Its market cap has decreased by -16.92% in one year.
Market Cap
224.59M
Enterprise Value
461.15M
Revenue
226.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.96
Market Cap Chart
Since July 22, 2016, Atrys Health's market cap has increased from 17.85M to 224.59M, an increase of 1,158.54%. That is a compound annual growth rate of 30.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 229.14M | 3.07% |
| Dec 31, 2025 | 222.31M | -13.13% |
| Dec 31, 2024 | 255.91M | -8.07% |
| Dec 29, 2023 | 278.37M | -39.03% |
| Dec 30, 2022 | 456.55M | -26.48% |
| Dec 30, 2021 | 620.95M | 107.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.66B |
| Laboratorios Farmaceuticos Rovi | 3.99B |
| Almirall | 2.71B |
| Faes Farma | 1.55B |
| Pharma Mar | 1.35B |
| Clínica Baviera | 839.03M |
| Oryzon Genomics | 246.02M |
| Prim, S.A. | 217.80M |